Dipeptidyl Peptidase-4 Inhibitors in Diverse Patient Populations With Type 2 Diabetes

Conclusion DPP-4 inhibitors are therapeutically beneficial for a diverse population of patients with T2DM, including elderly patients, based on demonstrated efficacy, tolerability, and a low risk for hypoglycemia.

http://tde.sagepub.com/cgi/content/abstract/41/1_suppl/19S?rss=1

Source: The Diabetes Educator - November 17, 2015 Category: Endocrinology Authors: Hinnen, D. Tags: Features Source Type: research